These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14984255)

  • 1. Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).
    Tréhin R; Krauss U; Muff R; Meinecke M; Beck-Sickinger AG; Merkle HP
    Pharm Res; 2004 Jan; 21(1):33-42. PubMed ID: 14984255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
    Tréhin R; Krauss U; Beck-Sickinger AG; Merkle HP; Nielsen HM
    Pharm Res; 2004 Jul; 21(7):1248-56. PubMed ID: 15290867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).
    Tréhin R; Nielsen HM; Jahnke HG; Krauss U; Beck-Sickinger AG; Merkle HP
    Biochem J; 2004 Sep; 382(Pt 3):945-56. PubMed ID: 15193145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Merkle HP
    Pharm Res; 2007 Apr; 24(4):628-42. PubMed ID: 17334941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
    Thorén PE; Persson D; Isakson P; Goksör M; Onfelt A; Nordén B
    Biochem Biophys Res Commun; 2003 Jul; 307(1):100-7. PubMed ID: 12849987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
    Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
    Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of penetratin peptides. Part 2. In vitro uptake of penetratin and two of its derivatives.
    Letoha T; Gaál S; Somlai C; Venkei Z; Glavinas H; Kusz E; Duda E; Czajlik A; Peták F; Penke B
    J Pept Sci; 2005 Dec; 11(12):805-11. PubMed ID: 15942927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a plasma membrane-mediated permeability barrier to Tat basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate.
    Violini S; Sharma V; Prior JL; Dyszlewski M; Piwnica-Worms D
    Biochemistry; 2002 Oct; 41(42):12652-61. PubMed ID: 12379107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.
    Zhang X; Jin Y; Plummer MR; Pooyan S; Gunaseelan S; Sinko PJ
    Mol Pharm; 2009; 6(3):836-48. PubMed ID: 19278221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus.
    Vivès E; Brodin P; Lebleu B
    J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane interaction and cellular internalization of penetratin peptides.
    Christiaens B; Grooten J; Reusens M; Joliot A; Goethals M; Vandekerckhove J; Prochiantz A; Rosseneu M
    Eur J Biochem; 2004 Mar; 271(6):1187-97. PubMed ID: 15009197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.
    Herbig ME; Weller K; Krauss U; Beck-Sickinger AG; Merkle HP; Zerbe O
    Biophys J; 2005 Dec; 89(6):4056-66. PubMed ID: 16183886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin-derived carrier peptides.
    Neundorf I; Beck-Sickinger AG
    Curr Pharm Des; 2005; 11(28):3661-9. PubMed ID: 16305502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58).
    Herbig ME; Fromm U; Leuenberger J; Krauss U; Beck-Sickinger AG; Merkle HP
    Biochim Biophys Acta; 2005 Jun; 1712(2):197-211. PubMed ID: 15919050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake.
    Richard JP; Melikov K; Vives E; Ramos C; Verbeure B; Gait MJ; Chernomordik LV; Lebleu B
    J Biol Chem; 2003 Jan; 278(1):585-90. PubMed ID: 12411431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
    Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells.
    Zhang X; Wan L; Pooyan S; Su Y; Gardner CR; Leibowitz MJ; Stein S; Sinko PJ
    Mol Pharm; 2004; 1(2):145-55. PubMed ID: 15832511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF; Filipovska A; Smith RA; Gait MJ; Murphy MP
    Biochem J; 2004 Nov; 383(Pt. 3):457-68. PubMed ID: 15270716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing novel hCT derived cell-penetrating peptides with improved metabolic stability.
    Rennert R; Wespe C; Beck-Sickinger AG; Neundorf I
    Biochim Biophys Acta; 2006 Mar; 1758(3):347-54. PubMed ID: 16380074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.